(Q72317695)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8138824%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

title

Wilson's disease with cerebral manifestation: monitoring therapy by CSF copper concentration (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8138824%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

author name string

C Hartard

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8138824%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

B Weisner

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8138824%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

C Dieu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8138824%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

K Kunze

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8138824%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

publication date

1 December 1993

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8138824%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8138824%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

volume

241

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8138824%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8138824%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

page(s)

101-107

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8138824%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/bf00869772

25 October 2019

exact match

0 references

cites work

The treatment of Wilson's disease with zinc. IV. Efficacy monitoring using urine and plasma copper

1 reference

12 December 2020

Evoked potentials in assessment and follow-up of patients with Wilson's disease.

1 reference

12 December 2020

Perspectives on Wilson's disease

1 reference

12 December 2020

Treatment of Wilson's disease with zinc. VII. Protection of the liver from copper toxicity by zinc-induced metallothionein in a rat model.

1 reference

12 December 2020

Zinc sulphate therapy for Wilson's disease after acute deterioration during treatment with low-dose D-penicillamine

1 reference

12 December 2020

Wilson's disease: yesterday, today, and tomorrow

1 reference

12 December 2020

Treatment of Wilson's disease with zinc. I. Oral zinc therapy regimens

1 reference

12 December 2020

CSF copper concentration: a new parameter for diagnosis and monitoring therapy of Wilson's disease with cerebral manifestation

1 reference

12 December 2020

Penicillamine, a new oral therapy for Wilson's disease

1 reference

12 December 2020

Treatment of Wilson's disease with zinc. VI. Initial treatment studies

1 reference

12 December 2020

Can Wilson's disease patients be decoppered?

1 reference

12 December 2020

Cerebral and ocular toxicity induced by desferrioxamine

1 reference

12 December 2020

Initial therapy of patients with Wilson's disease with tetrathiomolybdate

1 reference

12 December 2020

The management of pregnancy in Wilson's disease treated with trientine

1 reference

12 December 2020

Determination of serum copper by atomic absorption, with use of the graphite cuvette

1 reference

12 December 2020

Penicillamine may detoxify copper in Wilson's disease

1 reference

12 December 2020

Disappearance of Kayser-Fleischer Rings After Liver Transplantation

1 reference

12 December 2020

Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride

1 reference

12 December 2020

Treatment of Wilson's disease with triethylene tetramine hydrochloride (Trientine).

1 reference

12 December 2020

Deterioration of Wilson's disease following the start of penicillamine therapy

1 reference

12 December 2020

Visual and brain stem auditory evoked responses in Wilson's disease.

1 reference

12 December 2020

Treatment of Wilson's disease with zinc: III. Prevention of reaccumulation of hepatic copper

1 reference

12 December 2020

Worsening of neurologic syndrome in patients with Wilson's disease with initial penicillamine therapy

1 reference

12 December 2020

Does CSF copper level in Wilson disease reflect copper accumulation in the brain?

1 reference

12 December 2020

Effect of D-penicillamine treatment on brain metabolism in Wilson's disease: a case study

1 reference

12 December 2020

Management of penicillamine nephropathy in Wilson's disease: a new chelating agent

1 reference

12 December 2020

Clinical assessment of 31 patients with Wilson's disease. Correlations with structural changes on magnetic resonance imaging

1 reference

12 December 2020

Oral zinc therapy for Wilson's disease

1 reference

12 December 2020

The effect of zinc supplements on plasma zinc and copper levels and the reported symptoms in healthy volunteers

1 reference

12 December 2020

Assignment of the gene for Wilson disease to chromosome 13: linkage to the esterase D locus

1 reference

12 December 2020

COPPER CHELATION AND THE NEURO-OPHTHALMIC TOXICITY OF DESFERRIOXAMINE

1 reference

12 December 2020

[Wilson's disease--critical deterioration under high-dose parenteral penicillamine therapy]

1 reference

12 December 2020

The Kayser-Fleischer ring during long-term treatment in Wilson's disease (hepatolenticular degeneration). A follow-up study

1 reference

12 December 2020

The role of radiocopper in the diagnosis of Wilson's disease

1 reference

12 December 2020

[Wilson' disease: rapid diagnosis and differentiation of heterozygous and homozygous carriers with 64CuCl2 (author's transl)]

1 reference

12 December 2020

ANTIGEN-ANTIBODY CROSSED ELECTROPHORESIS

1 reference

12 December 2020

Copper chelation in patients with Wilson's disease. A comparison of penicillamine and triethylene tetramine dihydrochloride

1 reference

12 December 2020

Clinical aspects of Wilson's disease

1 reference

12 December 2020

Management of Wilson's disease with zinc sulphate. Experience in a series of 27 patients

1 reference

12 December 2020

Low-dose zinc therapy for maintenance treatment of Wilson's disease

1 reference

12 December 2020

Long-term care and management of Wilson's disease in the GDR.

1 reference

12 December 2020

Treatment of Wilson's disease with zinc. II. Validation of oral 64copper with copper balance

1 reference

12 December 2020

Thiomolybdates in the Treatment of Wilson's Disease

1 reference

12 December 2020

Wilson's disease. An analysis of the cranial computerized tomographic appearances found in 60 patients and the changes in response to treatment with chelating agents

1 reference

12 December 2020

Wilson's disease. Development of neurological disease after beginning penicillamine therapy

1 reference

12 December 2020

Wilson's disease: an update, with emphasis on new approaches to treatment

1 reference

12 December 2020

3 years of continuous oral zinc therapy in 4 patients with Wilson's disease

1 reference

12 December 2020

The use of trientine in preventing the effects of interrupting penicillamine therapy in Wilson's disease

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00869772

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8138824%20AND%20SRC:MED&resulttype=core&format=json

25 October 2019

1 reference